Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine

Public health vaccination recommendations for COVID-19 primary series and boosters in previously infected individuals differ worldwide. As infection with SARS-CoV-2 is often asymptomatic, it remains to be determined if vaccine immunogenicity is comparable in all previously infected subjects. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Nantel, Sabryna, Bourdin, Benoîte, Adams, Kelsey, Carbonneau, Julie, Rabezanahary, Henintsoa, Hamelin, Marie-Ève, McCormack, Deirdre, Savard, Patrice, Longtin, Yves, Cheng, Matthew P., De Serres, Gaston, Corbeil, Jacques, Gilca, Vladimir, Baz, Mariana, Boivin, Guy, Quach, Caroline, Decaluwe, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614167/
https://www.ncbi.nlm.nih.gov/pubmed/36311736
http://dx.doi.org/10.3389/fimmu.2022.930252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614167/
https://www.ncbi.nlm.nih.gov/pubmed/36311736
http://dx.doi.org/10.3389/fimmu.2022.930252

Ejemplares similares